Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Goodwill (2019 - 2025)

Historic Goodwill for X4 Pharmaceuticals (XFOR) over the last 7 years, with Q3 2025 value amounting to $17.4 million.

  • X4 Pharmaceuticals' Goodwill changed 0.0% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $17.4 million for FY2024, which is 0.0% changed from last year.
  • X4 Pharmaceuticals' Goodwill amounted to $17.4 million in Q3 2025, which was down 0.0% from $17.4 million recorded in Q2 2025.
  • X4 Pharmaceuticals' 5-year Goodwill high stood at $27.1 million for Q1 2021, and its period low was $17.4 million during Q1 2022.
  • Moreover, its 5-year median value for Goodwill was $17.4 million (2022), whereas its average is $18.9 million.
  • As far as peak fluctuations go, X4 Pharmaceuticals' Goodwill changed by 0.0% in 2021, and later tumbled by 3599.54% in 2022.
  • Over the past 5 years, X4 Pharmaceuticals' Goodwill (Quarter) stood at $17.4 million in 2021, then fell by 0.28% to $17.4 million in 2022, then changed by 0.0% to $17.4 million in 2023, then changed by 0.0% to $17.4 million in 2024, then changed by 0.0% to $17.4 million in 2025.
  • Its last three reported values are $17.4 million in Q3 2025, $17.4 million for Q2 2025, and $17.4 million during Q1 2025.